Glenn Hanna, MD
Natera, Inc.
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Arun Rajan, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
E-mail: ClinicalTrials@ ImClone.com
Eli Lilly and Company
Shared therapeutic areas:
shun lu, MD
Shanghai Chest Hospital
Shared therapeutic areas:
Project Leader
Ono Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Sridhar Mani, MD
Albert Einstein College of Medicine
Shared therapeutic areas:
Antonio Lambiase, MD
AGC Biologics S.p.A.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
All 1 trials loaded